Literature DB >> 33411201

Differentiation of multiple sclerosis lesions and low-grade brain tumors on MRS data: machine learning approaches.

Ziya Ekşi1, Muhammed Emin Özcan2, Murat Çakıroğlu3, Cemil Öz4, Ayşe Aralaşmak5.   

Abstract

Some multiple sclerosis (MS) lesions may have great similarities with neoplastic brain lesions in magnetic resonance (MR) imaging and thus wrong diagnoses may occur. In this study, differentiation of MS and low-grade brain tumors was performed with computer-aided diagnosis (CAD) methods by magnetic resonance spectroscopy (MRS) data. MRS data belonging to 51 MS and 39 low-grade brain tumor patients were obtained. The feature extraction from MRS data was performed by the help of peak integration (PI) and full spectra (FS) methods and the most significant features were identified. For the classification step, artificial neural network (ANN), support vector machine (SVM), and linear discriminant analysis (LDA) methods were used and the differentiation between MS and brain tumor was performed automatically. Examining the results, one can conclude that data which belong to MS and low-grade brain tumor cases were automatically differentiated from each other with the help of ANN with 100% accuracy, 100% sensitivity, and 100% specificity. Using of MR spectroscopy and artificial intelligence methods may be useful as a complementary imaging technique to MR imaging in the differentiation of MS lesions and low-grade brain tumors.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Brain tumor; Magnetic resonance spectroscopy; Multiple sclerosis; Neuroimaging; Support vector machine

Year:  2021        PMID: 33411201     DOI: 10.1007/s10072-020-04950-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  4 in total

1.  Combining magnetic resonance spectroscopy and molecular genomics offers better accuracy in brain tumor typing and prediction of survival than either methodology alone.

Authors:  Loukas Astrakas; Konstantinos D Blekas; Caterina Constantinou; Ovidiu C Andronesi; Michael N Mindrinos; Aristidis C Likas; Laurence G Rahme; Peter M Black; Karen J Marcus; A Aria Tzika
Journal:  Int J Oncol       Date:  2011-01-27       Impact factor: 5.650

2.  Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.

Authors:  S Cha; S Pierce; E A Knopp; G Johnson; C Yang; A Ton; A W Litt; D Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

Review 3.  Multiple sclerosis: the role of MR imaging.

Authors:  Y Ge
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

4.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.